JAMP Pharma Corporation is voluntarily, on a precautionary basis, recalling one product lot of Atorvastatin tablets, 40 mg, 500-format (lot MHC1403A) to the retail level (type 1 recall).
On August 5th, 2022, JAMP initiated with Health Canada a voluntary recall of PrJAMP-Atorvastatin 40mg 500-format tablets (lot MHC1403A) due to a possible contamination of the lot with latex pieces during manufacturing operations.
A thorough investigation was conducted at the manufacturing site to understand the factors that may have led to the current situation. The investigation concluded that it was an isolated incident involving a piece of a latex glove in a finished product.
Atorvastatin is a prescription drug used to treat high cholesterol and other fats (such as triglycerides) in the blood and to prevent cardiovascular diseases such as heart attacks.